Alignment Healthcare Q2 EPS USD 0.17

Alignment Healthcare, Inc. (NASDAQ: ALHC) reported second-quarter 2025 earnings per share (EPS) of $0.17, reflecting a notable improvement in its financial performance compared to the same period in 2024. The company’s Q2 2025 results showed a total revenue of $1.0 billion, representing a 49.0% year-over-year increase. This growth was driven by a 27.8% rise in health plan membership, which reached 223,700 members as of June 30, 2025.

The company’s adjusted gross profit for the quarter was $135.2 million, and its adjusted EBITDA reached $45.9 million. These figures indicate a strong operational performance, with the company surpassing its Q2 guidance across all key metrics. Alignment Healthcare also raised its full-year 2025 outlook, projecting continued growth in membership, revenue, adjusted gross profit, and adjusted EBITDA.

The EPS result of $0.17 for Q2 2025 marked a significant turnaround from the net loss per share of $0.13 in Q2 2024. This improvement was supported by the company’s strategic focus on expanding its Medicare Advantage membership and optimizing its cost structure. The company’s CEO, John Kao, emphasized the importance of balancing financial performance with care delivery, a core principle of Alignment Healthcare’s business model.

Looking ahead, Alignment Healthcare has provided updated guidance for the remainder of 2025. The company expects health plan membership to reach between 229,000 and 234,000 by year-end, with revenue projected to range between $3.885 billion and $3.910 billion. These expectations reflect the company’s confidence in its ability to sustain growth while maintaining operational efficiency.

The Q2 2025 results underscore Alignment Healthcare’s progress in scaling its operations and improving profitability. As the company continues to expand its Medicare Advantage offerings, its ability to maintain strong financial metrics while delivering value-driven care will remain a key focus for investors and stakeholders.